157 related articles for article (PubMed ID: 36547769)
21. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
[TBL] [Abstract][Full Text] [Related]
22. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
23. β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.
Badia R; Brufau MT; Guerrero-Zamora AM; Lizardo R; Dobrescu I; Martin-Venegas R; Ferrer R; Salmon H; Martínez P; Brufau J
Clin Vaccine Immunol; 2012 Mar; 19(3):368-76. PubMed ID: 22301691
[TBL] [Abstract][Full Text] [Related]
24. Effects of
West C; Stanisz AM; Wong A; Kunze WA
World J Gastroenterol; 2016 Dec; 22(48):10532-10544. PubMed ID: 28082805
[TBL] [Abstract][Full Text] [Related]
25. Development and
Singh A; Mandal UK; Narang RK
Assay Drug Dev Technol; 2022 Jan; 20(1):22-34. PubMed ID: 34780287
[TBL] [Abstract][Full Text] [Related]
26. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
27. Randomized Clinical Trial: Impact of Oral Administration of Saccharomyces boulardii on Gene Expression of Intestinal Cytokines in Patients Undergoing Colon Resection.
Consoli ML; da Silva RS; Nicoli JR; Bruña-Romero O; da Silva RG; de Vasconcelos Generoso S; Correia MI
JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1114-1121. PubMed ID: 25917895
[TBL] [Abstract][Full Text] [Related]
28. In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.
Ochangco HS; Gamero A; Smith IM; Christensen JE; Jespersen L; Arneborg N
World J Microbiol Biotechnol; 2016 Sep; 32(9):141. PubMed ID: 27430508
[TBL] [Abstract][Full Text] [Related]
29. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
30. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
[TBL] [Abstract][Full Text] [Related]
31. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
van der Aa Kühle A; Skovgaard K; Jespersen L
Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
[TBL] [Abstract][Full Text] [Related]
32. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
Liu CH; Chang JH; Chang YC; Mou KY
J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of Saccharomyces fungemia: A systematic review.
Vinayagamoorthy K; Pentapati KC; Prakash H
Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741
[TBL] [Abstract][Full Text] [Related]
34. Preventive Effect of
Babaei F; Mirzababaei M; Dargahi L; Shahsavari Z; Nassiri-Asl M; Karima S
ACS Chem Neurosci; 2022 Nov; 13(22):3180-3187. PubMed ID: 36318666
[TBL] [Abstract][Full Text] [Related]
35. Analyzing of colorectal cancerrelated genes and microRNAs expression profiles in response to probiotics Lactobacillus acidophilus and Saccharomyces cerevisiae in colon cancer cell lines.
Saffar KN; Larypoor M; Torbati MB
Mol Biol Rep; 2024 Jan; 51(1):122. PubMed ID: 38227272
[TBL] [Abstract][Full Text] [Related]
36. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
[TBL] [Abstract][Full Text] [Related]
37. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
Hedin KA; Rees VE; Zhang H; Kruse V; Vazquez-Uribe R; Sommer MOA
Sci Rep; 2022 May; 12(1):8862. PubMed ID: 35614092
[TBL] [Abstract][Full Text] [Related]
38.
Moens F; Duysburgh C; van den Abbeele P; Morera M; Marzorati M
Benef Microbes; 2019 Dec; 10(8):923-935. PubMed ID: 31965838
[TBL] [Abstract][Full Text] [Related]
39. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.
Yamchi A; Rahimi M; Javan B; Abdollahi D; Salmanian M; Shahbazi M
Arch Microbiol; 2023 Dec; 206(1):37. PubMed ID: 38142245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
